Back to Search
Start Over
A brief transdiagnostic group (the take control course) compared to individual low-intensity CBT for depression and anxiety: a randomized non-inferiority trial.
- Source :
-
Cognitive Behaviour Therapy . May2023, Vol. 52 Issue 3, p176-197. 22p. 1 Diagram, 5 Charts. - Publication Year :
- 2023
-
Abstract
- Few studies have examined brief transdiagnostic groups. The Take Control Course (TCC) was developed for patients with mild to moderate common mental health problems. We examined whether TCC is non-inferior to individual low-intensity cognitive behaviour therapy (CBT) in a single-blind individually randomised parallel non-inferiority trial. The primary outcomes were depression (PHQ9) and anxiety (GAD7) at 6-month follow-up (primary outcome point) and 12-month follow-up. The non-inferiority margin that we set, based on previous trials, corresponds to approximately 3 points on the PHQ9 and approximately 2.5 points on the GAD7. Intention-to-treat (ITT) and per-protocol (PP) analyses of 6-month data of 156 randomised patients indicated that TCC was non-inferior to individual low-intensity CBT on anxiety (ITT Coefficient = 0.24; 95% CI: −1.45 to 1.92; d = 0.04; p =.79), and depression (ITT Coefficient = 0.82; 95% CI: −1.06 to 2.69; d = 0.14; p =.39) outcomes, and functioning (ITT Coefficient = 0.69; 95% CI: −2.56 to 3.94; d = 0.08; p =.68). The findings at 12 months were inconclusive and require further testing. This randomised trial provides preliminary support that TCC is not less effective than short-term individual CBT within Improving Access to Psychological Therapies (IAPT) services. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 16506073
- Volume :
- 52
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Cognitive Behaviour Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 162968618
- Full Text :
- https://doi.org/10.1080/16506073.2022.2143418